|
21
|
Mitochondrial Dysfunction and DNA Damage in the Context of Pathogenesis of Atherosclerosis
Taisiia Shemiakova, Ekaterina Ivanova, Andrey V Grechko, Elena V Gerasimova, Igor A Sobenin, Alexander N Orekhov
Biomedicines. 22020 Jun 18;8(6):E166. doi: 10.3390/biomedicines8060166.
|
|
22
|
The Role of Sialic Acids in the Initiation of Atherosclerosis
Anastasia V Poznyak, Dongwei Zhang, Andrey V Grechko, Wei-Kai Wu, Alexander N Orekhov.
Minerva Cardioangiol. 2020 May 29. doi: 10.23736/S0026-4725.20.05145-2. Online ahead of print.
|
|
23
|
Animal Models of Human Atherosclerosis: Current Progress
A V Poznyak, Y Y Silaeva, A N Orekhov, A V Deykin.
Braz J Med Biol Res 2020;53(6):e9557. doi: 10.1590/1414-431x20209557. Epub 2020 May 18.
|
|
24
|
Cellular Mechanisms of Human Atherogenesis: Focus on Chronification of Inflammation and Mitochondrial Mutations
Alexander M Markin, Igor A Sobenin, Andrey V Grechko, Dongwei Zhang, Alexander N Orekhov
Front Pharmacol. 2020 May 14;11:642. doi: 10.3389/fphar.2020.00642.
|
|
25
|
Exposure to Zinc Oxide Nanoparticles Disrupts Endothelial Tight and Adherens Junctions and Induces Pulmonary Inflammatory Cell Infiltration.
Chen CM, Wu ML, Ho YC, Gung PY, Tsai MH, Orekhov AN, Sobenin IA, Lin P, Yet SF.
Int J Mol Sci. 2020 May 13;21(10). pii: E3437. doi: 10.3390/ijms21103437.
|
|
26
|
Current Advances in the Diagnostic Imaging of Atherosclerosis: Insights into the Pathophysiology of Vulnerable Plaque.
Mushenkova NV, Summerhill VI, Zhang D, Romanenko EB, Grechko AV, Orekhov AN.
Int J Mol Sci. 2020 Apr 23;21(8). pii: E2992. doi: 10.3390/ijms21082992.
|
|
27
|
Clinical Effectiveness of a Combination of Black Elder Berries, Violet Herb, and Calendula Flowers in Chronic Obstructive Pulmonary Disease: The Results of a Double-Blinded Placebo-Controlled Study.
Kirichenko TV, Sobenin IA, Markina YV, Gerasimova EV, Grechko AV, Kashirskikh DA, Romanenko EB, Wu WK, Orekhov AN.
Biology (Basel). 2020 Apr 22;9(4). pii: E83. doi: 10.3390/biology9040083.
|
|
28
|
Medicinal Plants as a Potential and Successful Treatment Option in the Context of Atherosclerosis.
Kirichenko TV, Sukhorukov VN, Markin AM, Nikiforov NG, Liu PY, Sobenin IA, Tarasov VV, Orekhov AN, Aliev G
Front Pharmacol. 2020 Apr 8;11:403. doi: 10.3389/fphar.2020.00403. eCollection 2020.
|
|
29
|
Signaling Pathways Potentially Responsible for Foam Cell Formation: Cholesterol Accumulation or Inflammatory Response-What is First?
Sazonova MA, Sinev VV, Karagodin VP, Ryzhkova AI, Galitsyna EV, Barinova VA, Zelinyĭ RI, Nikitina NA, Orekhov AN.
Int J Mol Sci. 2020 Apr 14;21(8). pii: E2716. doi: 10.3390/ijms21082716.
|
|
30
|
Oxidative Stress and Antioxidants in Atherosclerosis Development and Treatment.
Poznyak AV, Grechko AV, Orekhova VA, Chegodaev YS, Wu WK, Orekhov AN.
Biology (Basel). 2020 Mar 21;9(3). pii: E60. doi: 10.3390/biology9030060.
|
